October 4, 2016/Cancer/News & Insight

New Cancer Building Maximizes Multidisciplinary Care

A concentration of providers and services improve patients’ experience

Cleveland Clinic_Taussig_DuskFacade_FromSouthWest

Providing multidisciplinary care for patients is the norm at Cleveland Clinic Cancer Center, but the cancer building itself has made the process far more efficient for patients and physicians.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In the past, cancer patients getting outpatient treatment traveled to multiple locations within the old Cancer Center building and among other Cleveland Clinic buildings to see specialists, undergo tests and procedures, and receive medical and social services. Sometimes those appointments were spread over more than one day.

With consolidated offices and clinical facilities and advanced scheduling, Cleveland Clinic Cancer Center minimizes transit and wait times and maximizes convenience. “All of the services we need are set up to happen in the same place,” says Nathan Pennell, MD, PhD, Director of the Thoracic Malignancies Program. “The patients are in one place that’s tailored to their needs and everyone comes to them.”

A concentration of providers and services

Lung cancer care provides a good example of how the seven-floor, 385,000-square foot building streamlines operations.

Lung cancer patients who need diagnostic imaging or radiotherapy have access to those services in the lower level — a skylighted, high-ceiling space that contains six linear accelerators, a Gamma Knife® stereotactic radiosurgery unit and a diagnostic imaging suite.

The building’s first floor houses the patient reception area, an expansive hematology laboratory and blood-drawing stations to eliminate waiting lines, a retail pharmacy, and patient services including a café, wellness center, spiritual area, wig boutique and art and music therapy facilities.

Advertisement

Lobby_staged

Lung cancer patients see clinical specialists and receive chemotherapy on the third floor. There, examination rooms surround a meeting/working area where members of the lung cancer multidisciplinary team, including oncologists, surgeons, radiologists, palliative care providers, oncology nurses and advanced practice providers, can discuss therapeutic decisions and treatment plans. Private chemotherapy infusion rooms, a short walk from the examination area, have floor-to-ceiling windows overlooking a tree-lined lawn.

clinicaltreatment_550x450

The second floor contains a dedicated area where patients with lung cancer or other malignancies who are participating in phase I clinical trials receive chemotherapy infusion while being monitored by specially trained nurses and research assistants. The space and staffing reflects Cleveland Clinic Cancer Center’s aggressive efforts to expand phase I clinical trials access for patients.

Advertisement

A more efficient process

“We already had good multidisciplinary care, but I think it was a bit disjointed from the patient perspective,” Dr. Pennell says. “While the patient may have seen a surgeon and radiation and medical oncologists and a palliative medicine physician all in the same day, those visits were often spread out — seeing different people and walking back and forth to different places.

“The idea of the multidisciplinary clinic is that the patient is in one room and multiple doctors will see that person back to back and then consult to plan ongoing care,” Dr. Pennell says. In the past those discussions often took place at weekly tumor board meetings.

“From a care standpoint, it is definitely much more efficient for us to discuss the patient while working in the same space and sitting next to each other, Dr. Pennell says, “so that by the end of the day when the patient is ready to leave, he or she has a plan for treatment.”

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad